If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

15 Jul 2013 17:15

RNS Number : 3688J
Plant Health Care PLC
15 July 2013
 



15 July 2013

 

PLANT HEALTH CARE PLC("Plant Health Care" or the "Company")

 

Director's dealing

 

Plant Health Care (AIM / CISX: PHC.L) announces that it has entered into a binding agreement with Mr John Brady, a director of the Company. Under the agreement, Mr Brady shall exercise, in two equal tranches on 15 October 2013 and 13 November 2013 all of his options over unissued shares in the Company, which equate to 975,000 Plant Health Care shares ("Shares"). On each date Mr Brady shall sell such number of Shares as is sufficient to cover the exercise price and his associated tax liability arising from the exercise. Any sale of Shares shall be at the prevailing market price and subject to sufficient demand in the market. Further details, using the assumptions specified so as to provide working examples, are set out below:

 

15 October 2013

Mr Brady shall exercise 487,500 options at an exercise price of 37p per Share and sell such number of Shares as shall cover the amount of the aggregate exercise price and his associated tax liability. Assuming a prevailing Share price of 78.5p, being the closing Share price on 12 July 2013, the funds required to cover the exercise price and taxes would equate to approximately £261,000 which would require the disposal of approximately 332,485 Shares*.

 

13 November 2013

56,025 options with an exercise price of 71p per Share (provided they are below the then current market price) and sell such number of Shares as shall cover the amount of the aggregate exercise price and his associated tax liability. Assuming a prevailing share price of 78.5p, being the closing share price on 12 July 2013, the funds required to cover the exercise price and taxes would equate to approximately £274,000 which would require the disposal of approximately 349,045 Shares*.

 

 

 

Notes:

1. The closing share price of 78.5p refers to the closing middle market price of a Plant Health Care share on 12 July 2013 as derived from the daily official list of the London Stock Exchange plc.

2. *An exchange rate of £/$1.5118 has been assumed which was derived from data provided on FT.com by WM/Reuters as at 4.00 p.m. London time on 12 July 2013 (being the last practicable dealing date prior to the date of this announcement).

 

For further information please contact:

 

Plant Health Care plc

Dr. Chris Richards

Chairman

Tel: +44 (0)20 7250 1446

Nomura Code Securities

Clare Terlouw / Chris Golden

Tel: +44 (0)20 7776 1200

www.nomuracode.com

Powerscourt

Paul Durman / Sophie Moate

Tel: +44 (0)20 7250 1446

paul.durman@powerscourtgroup.

com

sophie.moate@powerscourtgroup

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFUFIIFDSEIW
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.